Fair Journey Biologics Appoints Dr. Marc Van Dijk As Chief Scientific Officer of Antibody Discovery and Engineering

Dec 04, 2024•8 months ago

Position

Chief Scientific Officer

Company

FairJourney Biologics

Marc van Dijk

PortoBiotechnology

Description

FairJourney Biologics S.A. has announced the appointment of Dr. Marc van Dijk as the Chief Scientific Officer of Antibody Discovery and Engineering

Company Information

Company

FairJourney Biologics

Location

Porto, Porto, Portugal

About

At FairJourney Biologics, we specialize in cutting-edge antibody discovery and development, offering end-to-end solutions that fast-track your research. With over a decade of expertise, our innovative technologies and seasoned team have successfully advanced 14 antibodies to clinical stages. Our adaptable partnership model empowers projects of any scale, fostering collaboration and breakthrough innovation. Whether you're in early-stage research or development, we deliver tailored, high-quality antibodies designed to meet your specific needs.

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Related People

Fair Journey Biologics Appoints Dr. Marc Van Dijk As Chief Scientific Officer of Antibody Discovery and Engineering

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Executive Insights

Related People

Marc hidden

Daniela hidden

António hidden

Company Information